Affiliated Hospital of the Academy of Military Medical Sciences, Beijing 100071, P.R. China.
Key Laboratory of Birth Defects and Reproductive Health of the National Health and Family Commission, Chongqing Population and the Family Planning Science and Technology Research Institute, Chongqing 400020, P.R. China.
Int J Mol Med. 2014 Jul;34(1):92-102. doi: 10.3892/ijmm.2014.1745. Epub 2014 Apr 16.
The present study evaluated the effect of epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea, on irradiation-induced pulmonary fibrosis and elucidated its mechanism of action. A rat model of irradiation-induced pulmonary fibrosis was generated using a (60)Co irradiator and a dose of 22 Gy. Rats were intraperitoneally injected with EGCG (25 mg/kg) or dexamethasone (DEX; 5 mg/kg) daily for 30 days. Mortality rates and lung index values were calculated. The severity of fibrosis was evaluated by assaying the hydroxyproline (Hyp) contents of pulmonary and lung tissue sections post-irradiation. Alveolitis and fibrosis scores were obtained from semi-quantitative analyses of hematoxylin and eosin (H&E) and Masson's trichrome lung section staining, respectively. The serum levels of transforming growth factor β1 (TGF-β1), interleukin (IL)-6, IL-10, and tumor necrosis factor-α (TNF-α) were also measured. Surfactant protein-B (SPB) and α-SMA expression patterns were evaluated using immunohistochemistry, and the protein levels of nuclear transcription factor NF-E2-related factor 2 (Nrf-2) and its associated antioxidant enzymes heme oxygenase-1 enzyme (HO-1) and
NAD(P)H: quinone oxidoreductase-1 (NQO-1) were examined via western blot analysis. Treatment with EGCG, but not DEX, reduced mortality rates and lung index scores, improved histological changes in the lung, reduced collagen depositions, reduced MDA content, enhanced SOD activity, inhibited (myo)fibroblast proliferation, protected alveolar epithelial type II (AE2) cells, and regulated serum levels of TGF-β1, IL-6, IL-10, and TNF-α. Treatment with EGCG, but not DEX, activated Nrf-2 and its downstream antioxidant enzymes HO-1 and NQO-1. Taken together, these results showed that EGCG treatment significantly inhibits irradiation-induced pulmonary fibrosis. Furthermore, the results suggested promising clinical EGCG therapies to treat this disorder.
评估表没食子儿茶素没食子酸酯(EGCG),绿茶中含量最丰富的儿茶素,对辐射诱导性肺纤维化的影响,并阐明其作用机制。
采用(60)Co 辐照仪和 22 Gy 剂量建立辐射诱导性肺纤维化大鼠模型。大鼠每天腹腔内注射 EGCG(25 mg/kg)或地塞米松(DEX;5 mg/kg),共 30 天。计算死亡率和肺指数值。通过测定肺和肺组织切片羟脯氨酸(Hyp)含量评估纤维化程度。通过苏木精和伊红(H&E)和 Masson 三色肺切片染色的半定量分析分别获得肺泡炎和纤维化评分。还测量了转化生长因子β1(TGF-β1)、白细胞介素(IL)-6、IL-10 和肿瘤坏死因子-α(TNF-α)的血清水平。采用免疫组化法评估表面活性蛋白-B(SPB)和α-平滑肌肌动蛋白(α-SMA)表达模式,并用 Western blot 分析检测核转录因子 NF-E2 相关因子 2(Nrf-2)及其相关抗氧化酶血红素加氧酶-1 酶(HO-1)和 NAD(P)H:醌氧化还原酶-1(NQO-1)的蛋白水平。
与 DEX 治疗相比,EGCG 治疗降低了死亡率和肺指数评分,改善了肺组织学变化,减少了胶原蛋白沉积,降低了 MDA 含量,增强了 SOD 活性,抑制了(肌)成纤维细胞增殖,保护了肺泡上皮 II 型(AE2)细胞,调节了 TGF-β1、IL-6、IL-10 和 TNF-α的血清水平。与 DEX 治疗相比,EGCG 治疗激活了 Nrf-2 及其下游抗氧化酶 HO-1 和 NQO-1。
EGCG 治疗可显著抑制辐射诱导性肺纤维化。此外,结果表明 EGCG 有希望用于临床治疗这种疾病。